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Abstract 
Background: It is an established fact that regional anesthetic techniques especially through spinal route form an 
imperative for countries like India owing to their cheaper const, safety profile and ease of administration. Moreover, 
in lower abdominal and gynecological surgeries, they provide good muscle relaxation, higher success rate coupled 
with avoidance of multiple drugs. Aims and Objectives: The purpose of the study is to evaluate the efficacy of 
Dexmedetomidine (5µg) versus Fentanyl (25µg) as an adjuvant added to Bupivacaine in spinal anaesthesia and also 
to assess various hemodynamic parameters and side effects caused by them.Material and Methods: The current 
prospective study was conducted over a period of nineteen months from March 2017 to September 2018 at 
Government Medical College and Hospital, Anantapuramu and include a total of 50 cases were studied. Standard 
methods were used for recording as well as analysis of data.Observations and inference: It is observed in the study 
that that Intrathecal Dexmedetomidine produces early onset of sensory blockade significantly at 1.95±0.44 mins 
compared to Fentanyl at 2.89±0.42 mins and prolongs the duration of postoperative analgesia significantly up to 
304.68 ±25.43 mins compared to Fentanyl where it is 253.12 ± 14.30 mins with desirable sedation and without 
significant side effects.  Conclusion: It can be concluded from the study that intra the cal Dexmedetomidine is an 
ideal choice over Fentanyl for regional anesthesia. 
Keywords: Bupivacaine, Dexmedetomidine, Fentanyl, Intrathecal, Lower Abdominal and Gynecological surgeries. 
Introduction 
 
The cost of general anaesthesia, the skill required to its 
practice, specialized equipment needed for its 
administration coupled with an indifferent supply of 
anesthetic gases/drugs and lack of monitoring 
equipment especially in peripheral areas in a country 
like India made regional Anesthetic techniques as an 
imperative choice because they are relatively 
inexpensive and easy to administer. The popularity of 
regional anaesthetic techniques especially through 
spinal route, being advised and practiced, owing to 
their safety profile when compared to the side effects 
associated with general anesthesia. 
 
*Corresponding Author 
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The beauty of spinal anesthesia is that provides 
profound muscle relaxation, easy to administer, high 
success rate, rapid spread, avoids high doses of 
multiple drugs and above all the patient will be awake 
and cooperative. It also forms an established form of 
anesthesia for lower abdominal and gynecological 
techniques inpatients having poor ventilatory 
performance[1,2]. 
 
Aims and Objectives 
The aims and objectives of current study are 
1. To evaluate the efficacy of Dexmedetomidine 
(5µg) versus Fentanyl (25µg) as an adjuvant 
added to Bupivacaine in spinal anaesthesia 
2. Assessment of the difference of various 
parameters including onset, duration and level of 
sensory blockade, onset of motor blockade, 
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duration of post-operative analgesia, changes in 
hemodynamic parameters if any and any other 
noticeable side effects. 
 
Materials and Methods 
The current study is a prospective randomized, 
controlled and double blinded study carried out at 
Government Medical College and General Hospital, 
Anantapuramu from March 2017 to September 2018 
after obtaining clearance from Institutional Ethics 
Committee and included 50 patients in two groups 
(Dexmedetomidine and Fentanyl) by using ASA grade 
I and II physical status, aged between 18-60yrs, 
belonging to both sexes undergoing lower abdominal 
&gynecological surgeries. Patients who refused to be a 
part of study, those who fall under >ASA-III criterion, 
patients with infection, hypertensives and those who 
are dependent on opioids are excluded from the study. 
All the data obtained from the study are recorded in a 
pretested proforma, systematically tabulated and 
analyzed by appropriate statistical tools usingSSPS for 
windows 10.0.5. Continuous Variables were analyzed 
with student' s t-test, Analysis of variance (ANOVA). 
Fischer's F-test, Levine’s test for equality of variance, 
Pearson correlation as appropriate. In student's t-test 
we have applied one sample t-test, independent sample 
t-test, paired sample t-test. Other parameters were 
analyzed by descriptive statistics as appropriate. 
During preoperative visit patient’s detailed history, 
general physical examination and systemic 
examination were carried out. Basic demographic data 
like age, sex, height and weight were recorded. 
During the pre anaesthetic checkup, linear visual 
analogue scale (VAS) was explained to all patients 
using a 10cm scale. Informed consent was obtained 
from all the 50 patients after a detailed explanation of 
the procedure to be performed.  All the patients were 
premedicated with Inj. Midazolam 0.05mg/kg I.M 45-
60mins prior to procedure. 
The pulse rate, blood pressure and respiratory rate were 
recorded before starting the case. Peripheral venous 
cannulation was done with 18 G IV cannula and all the 
patients were preloaded with 10 ml/kg of Lactated 
Ringer's solution. The patients were placed in either 
right or left lateral position or in sitting position and 
under strict aseptic precautions lumbar puncture was 
carried out in midline using 25G Quincke –Babcock’s 
needle through L3-L4 interspace.After the appearance 
of cerebrospinal fluid, the drug was injected into the 
sub arachnoid space according to their group and were 
turned to supine position. 
Group D, n=25 were given 2.5ml (12.5mg) of 0.5% 
Hyperbaric Bupivacaine with 5µg dexmedetomidine 
(made to 0.5 ml).Group F, n=25 were given 2.5ml 
(12.5mg) of 0.5% Hyperbaric Bupivacaine with 25 µg 
of Fentanyl (0.5 ml). 
 Vital signs such as pulse rate, blood pressure, 
respiratory rate and SPo2 were monitored everyone 
minute in the first three minutes, every three minutes 
up to thirty minutes and every 10 min till the end of 
procedure and were noted in the proforma. 
Level of sensory block was assessed by pinprick and 
the onset of blockade was noted. Intra operatively no 
narcotics or analgesics were administered and if 
administered the patients were excluded from the 
study. 
In both the groups the time of injection was recorded as 
zero hour and the following parameters are observed 
intra operatively: Onset of sensory blockade, Level 
(dermatomal) of sensory blockade, Onset of motor 
blockade, Quality of motor blockade by BROMAGE 
SCALE, 2-segment regression time, Degree of sedation 
(Wilson sedation scale), Duration of motor blockade 
which is taken as the time from injection to return of 
power to BROMAGE Grade 0.Side effects like 
headache, nausea, vomiting, pruritus, urinary retention 
and respiratory depression are noted in both the groups. 
If there was any fall in blood pressure, intravenous 
fluids were rushed and if the fall was more than 30% 
below the base line value Inj. Ephedrine was given in 
titrated doses. If the pulse rate was less than 60 per 
minute, Inj. Atropine 0.6mg I.V was given. If the 
respiratory rate was below 10 /min respiratory 
depression was diagnosed. 
At the end of surgery, the patient was shifted to 
postoperative ward.  Patients were monitored at 30 
min, 1 hour, 2 hours, 4 hours, 8 hours, 12 hours and 24 
hours postoperatively, and VAS scores were noted 
along with vital parameters. The time at which rescue 
analgesic was given are noted which is taken as 
duration of postoperative analgesia. Rescue analgesic 
used was Inj. tramadol 100mg IM. Rescue analgesic 
was administered when the VAS score was more than 4 
in the postoperative period. 
Observations and Inferences 
Results were analyzed in both the groups based on 
various parameters such as age , sex , weight , height , 
ASA Grade , types of surgery ,onset of sensory and 
motor blockade , highest sensory level reached, grade 
of motor blockade , two segment regression time , 
duration of motor blockade ,time for rescue analgesic 
(postoperative analgesia duration)  and side effects 
experienced in both the groups. 
 
Age wise distribution of cases: The age distribution in 
GROUP D was from 18-60 whereas the age 
distribution in GROUP F was 19-60. The mean age in 
GROUP D was 39.96 with SD 11.46 whereas in 
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GROUP F it was 39.32 with SD 11.27. Both groups 
were comparable in terms of age distribution. The same 
findings are depicted in table No.1 below. 
Table No.1: Age wise distribution of cases 
AGE GROUP -D GROUP- F 
18-30 6 5 
31-45 11 12 
46-60 8 8 
TOTAL 25 25 
MEAN 39.96 39.32 
STANDARD DEVIATION 11.46 11.27 
 
Sex wise distribution of cases:  when sex wise 
distribution of cases is considered, 14 males and 11 
females were present in Group-D whereas 13 males 
and 12 females were preset in Group-F as depicted in 
table No.2. However, distribution of cases is not 
statistically significant. 
Table No.2: Sex wise distribution of cases 
Sex GROUP -D GROUP- F Total 
MALE 14 13 27 
FEMALE 11 12 23 
Total 25 25 50 
Height and weight wise distribution of cases: As 
observed from the Table-3, No statistically significant 
differences is made out as for as height and weight of 
study subjects are concerned.The mean weights of 
patients in both the groups were comparable. There is 
no statistical significance between the groups with P 
value being 0.2064.The mean height in both groups 
was comparable as evident by the P value 0.5101 
which is not significant statistically. 
Table No.3: Height and weight wise distribution of cases 
 
Parameter Weight in Kilograms Height in Cms 
 Group-D Group-F Group-D Group-F 
Range 51-79 49-82 150-178 153-180 
Mean  66.24 69.28 162.84 161.36 
Standard deviation 7.70 9.03 7.80 7.97 
Distribution of cases as per ASA criteria: Both the 
groups are similar with respect to ASA Grade as well 
as are evident by the statistics below. When chi 
squared the value is 0.166 with one degree of freedom 
withP value >0.05 indicating that there is no statistical 
significance. The findings are presented in Table No.-4 
below. 
Table No.4: Distribution of cases as per ASA Criterion 
 
GRADE GROUP -D GROUP -F Total 
GRADE- I 22 21 43 
GRADE- II 3 4 7 
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Total 25 25 50 
Table No.5: Distribution of case as per the surgical procedures underwent by them 
 
Distribution of cases as per the surgical procedures: 
The surgical procedures underwent by the subjects are 
presented in table No.5 below. The procedures 
underwent by the subjects are almost comparable. 
SURGICAL PROCEDURE GROUP D GROUP F 
HYSTERECTOMY 9 9 
B/LHERNIOPLASTY&INCISIONAL HERNIA 6 5 
TURP 5 6 
OTHERS 5 5 
Observations as to the intraoperative Parameters 
1. Sensory blockade:Onset of sensory blockade 
was faster in Group D (Dexmedetomidine 
group) compared to Group F (Fentanyl 
group). Onset of blockade in 
Dexmedetomidine group is with a mean of 
1.96 min with standard deviation of 0.27 
compared to Fentanyl group where it was 2.76 
min with standard deviation of 0.26 which is 
highly significant statistically with a P value 
of <0.0001(Table No.6). 
2. Onset of Motor blockade:Onset of motor 
blockade was faster in Group D 
(Dexmedetomidine group) compared to Group 
F (Fentanyl group). Onset of blockade in 
Dexmedetomidine group is with a mean of 
4.69 min with standard deviation of 0.31 
compared to Fentanyl group where it was 5.72 
min with standard deviation of 0.58 which is 
highly significant statistically with a  P-value 
of <0.0001(Table No.6). 
Table No-6: Onset of sensory and Motor blockades 
 
Parameter Onset of Sensory blockade Onset of Motor blockade 
 Group-D Group-F Group-D Group-F 
Mean  1.96 2.76 4.69 5.72 
Standard 
deviation 
0.27 0.26 0.31 0.58 
p-Value <0.0001 <0.0001 
3. Quality of Motor Blockade: Quality of 
motor blockade assessed by BROMAGE scale 
was comparable among both the groups and is 
statistically not significant as indicated by the 
table below. 
4. Quality of sedation: Level of Sedation was 
assessed in both the groups(Table No.7) by 
Wilson sedation scale. 3/5 Wilson sedation 
grade which is highly desirable in regional 
anesthesia is observed in 13 patients in 
Dexmedetomidine group compared to only 6 
patients in Fentanyl group which is 
statistically significant. 
 
 
Table No.7- Quality of sedation 
 
SEDATION GRADE GROUP D GROUP F 
1 4 10 
2 8 9 
3 13 6 
4 0 0 
5 0 0 
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5. Two segment regression time: Two segment 
regression time was prolonged in Group D 
(Dexmedetomidine group) compared to Group 
F (Fentanyl group). Two segment regression 
time in Dexmedetomidine group is with a 
mean of 129.68 min with standard deviation 
of 8.75 compared to Fentanyl group where it 
was 81.16 min with standard deviation of 7.85 
which is highly significant statistically with a 
P value of <0.0001. 
6. Duration of motor Blockade(Table 
No.8):Duration of motor blockade was 
comparable in both groups. Duration of motor 
blockade in Dexmedetomidine group is with a 
mean of 233.88min with standard deviation of 
14.74 compared to Fentanyl group where it 
was 158.24 min with standard deviation of 
13.18 which is significant statistically with a P 
value of <0.0001. 
7. Postoperative duration of analgesia: 
Postoperative analgesia duration is taken as 
the time from spinal injection to the time of 
administering rescue analgesic in the 
postoperative period. Postoperative analgesia 
duration is significantly prolonged in 
Dexmedetomidine group with a mean value of 
308.64 min with a standard deviation of 12.50 
min compared to Fentanyl group where it is 
254.32 min with standard deviation of 
12.15.(TableNo.8) 
Table No.8- Duration of Motor blockade and Postoperative duration of analgesia 
Parameter Duration of motor blockade Postoperative analgesia 
 Group-D Group-F Group-D Group-F 
Mean  233.88 158.24 308.64 254.32 
Standard 
deviation 
14.74 13.18 12.50 12.15 
p-value <0.0001 <0.0001 
 
8. Side effects: The side effects most commonly 
observed are hypotension &bradycardia which 
are seen commonly with regional anaesthesia. 
Respiratory depression which is a feared side 
effect of opioids is not observed in any patient 
belonging to either group. Pruritus is observed 
in two cases of Fentanyl group which resolved 
spontaneously without any need for 
medication. 
9. Hemodynamic monitoring: Hemodynamic 
monitoring was done continuously throughout 
the procedure. Both groups are comparable in 
terms of blood pressure and pulse rate as 
evident from the Graph-1, Graph-2 and table 
No. below.  
 
 
Graph-1: heart rate variations in test groups 
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    Graph-2: Mean arterial pressure plotting 
 
Table No.9- Mean blood pressure recordings at different time intervals 
 GROUP F GROUP D 
BSBP 124.80±16.36 126.80±16.51 
SBP5 112.40±9.26 120.40±16.95 
SBP10 109.60±12.41 115.20±16.10 
SBP15 111.60±8.50 112.40±17.15 
SBP20 111.60±8.50 113.20±12.49 
SBP30 112.80±8.93 114.40±11.58 
SBP45 112.49±7.52 114.18±12.08 
SBP60 112.98±8.43 113.89±12.88 
SBP80 112.76±6.82 113.78±10.52 
BDBP 78.80±7.81 79.20±8.12 
DBP5 76.00±6.45 75.60±9.17 
DBP10 74.08±6.45 72.40±9.26 
DBP15 73.60±5.69 72.00±9.26 
DBP20 74.80±5.86 72.40±7.23 
DBP30 74.82±5.88 72.00±7.64 
DBP45 74.68±5.67 72.12±7.57 
DBP60 74.65±5.87 72.26±7.08 
DBP80 74.86±5.38 72.16±6.93 
 
Discussion 
Provision of effective and adequate intra operative and 
postoperative pain relief is important not only for 
humanitarian reasons but also because of the 
deleterious effects of pain on various organ systems 
and negative impact on postoperative recovery. But 
unfortunately, it is often neglected and left to the 
discretion of the nurses and surgeons, most of the 
times. Both fentanyl and Dexmedetomidine improved 
the quality of intraoperative analgesia and diminished 
the risk of   supplementation of general anesthesia.  
Fentanyl basically is a lipophilic μ-receptors agonist 
opioid.  Intrathecally, fentanyl exerts its effect by 
combining with opioid receptors in the dorsal horn of 
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spinal cord and may have a supra spinal spread and 
action [1,2]. Pain is frequently encountered during 
surgery on the female genital organs under spinal local 
anesthetics, intrathecal fentanyl when added to spinal 
local anesthetics reduces significantly visceral and 
somatic pain and this analgesic effect has been proved 
by many studies [3-5]. Intrathecal fentanyl prolongs the 
duration of spinal anesthesia produced by bupivacaine 
and lignocaine and this effect has been shown in 
obstetric and non-obstetric patients undergoing various 
surgeries [7-8]. The prolongation of the duration of 
spinal analgesia produced by intrathecal fentanyl is not 
a dose related phenomenon. 
Seewalet al. [9] found a significant improvement in the 
duration and quality of analgesia produced by 
intrathecal fentanyl and bupivacaine compared to   
intrathecal bupivacaine alone, meanwhile, the author 
found no further increase in the duration of analgesia 
when the dose of fentanyl was increased from 10 μg to 
20, 30, or 40 μg.  Kuusniemiet al. [6] reported that 
different durations of spinal anesthesia were related to 
different doses of spinal bupivacaine supplemented 
with 25 μg fentanyl in patients undergoing urology 
procedures. Hamberet al. [10] in a review article found 
that a dose of 20-30 μg fentanyl as adjunct to spinal 
anesthesia produces faster block onset time, 
improvedintraoperative analgesia and decrease 
incidence of intraoperative nausea and vomiting in 
obstetric patients. 
In non-obstetricpatients’ studies demonstrated that a 
dose of 25 μg fentanyl for supplementation of spinal 
anesthesia produces the excellent quality 
ofperioperative analgesia [11,12]. In present study 
fentanyl in a dose of 25 μg was used for 
supplementation of spinal bupivacaine. 
Dexmedetomidine is a highly selective α2 - 
adrenoreceptor agonist approved as intravenous 
sedative and adjuvant to anesthesia. Dexmedetomidine 
when used intravenously during anesthesia reduces 
opioid and inhalational anesthetics requirements 
[13,14]. Axelson and Gupta found that alpha-2 receptor 
agonists are important as neuraxial adjuvants to 
improve the quality of preoperative and postoperative 
analgesia in high-risk patients and in ambulatory 
procedures. When clonidine ordexmedetomidine added 
to intrathecal local anesthetics, the regression of 
sensory and motor block increased dose-dependently, 
and postoperative analgesia was prolonged. (15) 
Compared with clonidine, a α2 - adrenoreceptor 
agonist, the affinity of dexmedetomidine to α2 
receptors has been reported to be 10 times more than 
clonidine [16], moreover, Kalsoet al.[17] and Post et 
al.[18] reported a 1:10 dose ratio between intrathecal   
DEXEMEDETOMIDINE  and clonidine in animals.  
Clinical studies in surgical patients showed that 
intrathecal clonidine increases the duration of sensory 
and motor spinal block when added to spinal local 
anesthetics and this effect of clonidine is dose-
dependent  [19,20], and doses of more than 75 
μgintrathecal clonidine is accompanied by excessive 
sedation, hypotension and bradycardia. De Kock et al. 
[21] recommended a dose of 15-45 μg clonidine for 
supplementation of spinal anesthesia since this dose 
effectively prolongs the duration of spinal block with 
minimal sedation and side effects. The clinical studies 
about the use of intrathecaldexmedetomidine in 
surgical patients are scarce in the literature.  
Kanaziet al. [22] found that 3μg dexmedetomidine or 
30 μg clonidine added to 13 mg spinal bupivacaine 
produced the same duration of sensory and motor block 
with minimal side effects in urologic surgical patients. 
From Kanazi study and animal studies, we assumed 
that 3-5 μgdexmedetomidine would be equipotent to 
30-45 μgclonidine when used for supplementation of 
spinal bupivacaine. Intrathecaldexmedetomidine when 
combined with spinal bupivacaine prolongs the sensory 
block by depressingthe release of C-fibers transmitters 
and by hyperpolarization of pos-synaptic dorsal horn 
neurons [23,24].  
Calasans-Maia et al. (25) investigated the effects of 
adding intrathecaldexmedetomidine to 0.5% 
levobupivacaine over motor block duration in pigs and 
found that intrathecaldexmedetomidine (0.1, 0.2, and 
0.4 μg) prolonged the motor block duration. Motor 
block prolongation by α2 - adrenoreceptor agonists 
may result from binding these agonists to motor 
neurons in the dorsal horn of the spinal cord [26-
28].Intrathecal α2 - receptor agonists have been found 
to have antinociceptive action for both somatic and 
visceral pain.  
In the current study, the intrathecal dexmedetomidine 
and bupivacaine block has resulted in significantly less 
side effects than intrathecal fentanyl bupivacaine block. 
The most significant side effects reported about the use 
of intrathecal α2adrenoreceptor agonists are 
bradycardia and hypotension, in present study, these 
side effects were not significant probably because we 
used small dose of intrathecaldexmedetomidine which 
was confirmed by the findings of Kanazi report. 
It is observed in the present study that hypotension was 
more in the Dexmedetomidine group than in the 
Fentanyl group, but it did not reach a significant 
difference. Meanwhile, hypotension occurred 25-30 
min after spinal injection. 2 patients in the 
dexmedetomidine group and one patient in fentanyl 
group had mild episodes of hypotension in the PACU. 
Relativelybradycardia was more in Dexmedetomidine 
group than fentanyl group,but it did not proceedto a 
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significant difference. Pruritus after intrathecal fentanyl 
is reported to be 40-70% but it was only 8% in present 
study which can be explained by the fact that pruritus 
is a benign subjective symptom which is under 
reporting and usually need no treatment. 
It is understood from the current study that 
demographic data comparing age, sex, height, and 
weight shows no statistically significant difference 
(P>0.05) among both the groups, so also the type of 
surgeries and ASA grade of patients in both groups 
were comparable and statistically not significant. 
The mean time of onset of analgesia in group D was 
1.96±0.27min and in group F was 2.76±0.26 mins. The 
statistical analysis by “t” test, showed that there is a 
statistically significant difference (P <0.0001) between 
the two groups. Theonset of motor blockade in Group 
D was 4.69 ± 0.31 min compared to Group F patients 
where it is 5.72 ± 0.58 min which is highly significant 
statistically with P value <0.0001.The highest level of 
sensory blockade and the degree of motor blockade 
assessed by Bromage scale were comparable among 
both the groups and statistically not significant. 
 Sedation level was assessed in both the groups by 
Wilson sedation scale. It is highly desirable to have the 
patient with mild to moderate sedation during regional 
analgesia which is Wilson sedation grade 3 which is 
seen in 13 patients in Dexmedetomidine group 
compared to only 6 patients in Fentanyl group. Two 
segment regression time was prolonged in Group D 
(Dexmedetomidine group) compared to Group F 
(Fentanyl group). Two segment regression time in 
Dexmedetomidine group is with a mean of 129.68 min 
with standard deviation of 8.75 compared to Fentanyl 
group where it was 81.16 min with standard deviation 
of 7.85 which is highly significant statistically with a P 
value of <0.0001. 
Duration of motor blockade was comparable in both 
groups. Duration of motor blockade in 
Dexmedetomidine group is with a mean of 233.88 min 
with standard deviation of 14.74 compared to Fentanyl 
group where it was 158.24 min with standard deviation 
of 13.18 which is highly significant statistically with a 
P value of <0.0001. In a study RachanaJoshi et al 
(53)Dexmedetomidine significantly prolonged the 
duration of analgesia and duration of sensory and 
motor block as compared to intrathecal bupivacaine 
alone. It is taken as the time from spinal injection to the 
time of administering rescue analgesic in the post-
operative period. The post-operative duration of 
analgesia in group D was 308.64 ± 12.50 mins and in 
group F was 254.32 ±12.15 mins. The statistical 
analysis by “t” test, showed that there is a statistically 
significant difference (P <0.0001) between the two 
groups. Our study results like onset of analgesia and 
duration of analgesia well correlated with Al- Ghanem 
SM, Massad IM, Al-Mustafa MMetal.[13] study 
results. Hemodynamic monitoring was done 
continuously throughout the procedure. Both groups 
are comparable in terms of blood pressure and pulse 
rate. 
Conclusion 
The study was undertaken to evaluate the role of 
Dexmedetomidine as an additive to Bupivacaine to 
increase the duration of analgesia postoperatively by 
Intrathecal route. The study group as divided into 2 
groups of 25 patients each of both sexes ranging from 
18- 60 years age group of ASA grade I and II, selected 
for lower abdominal & gynecological surgeries , using 
5µg of  Dexmedetomidine (made to 0.5 ml) with 0.5%  
Hyperbaric Bupivacaine 2.5 ml in study group 
intrathecally with control group 0.5% Hyperbaric 
Bupivacaine with 25 µg (0.5ml) of Fentanyl. 
At the conclusion of study it has to be acclaimed 
thatIntrathecalDexmedetomidine produces early onset 
of sensory blockade significantly at 1.95±0.44 mins 
compared to Fentanyl at 2.89±0.42 mins and prolongs 
the duration of postoperative analgesia significantly up 
to 304.68 ±25.43 mins compared to Fentanyl where it 
is 253.12 ± 14.30 mins with desirable sedation and 
without significant side effects. 
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